In fact, several animal studies have shown significant HF benefit when GRK2 is lowered or inhibited concurrent with βAR antagonists (Harding et al., 2001; Raake et al., 2008; Rengo et al., 2009). Here, GRK2 is linked to hydrops fetalis.